Developer docs
API playgroundTry for free, no card

Search company profiles

CONFAB

Full company profile

uuid000cfp3

Namestring
CONFAB
Legal namestring
Confab Laboratories Inc.
Websiteurl
confab.com
Company typeenum
Private
Founded yearint
1983
Descriptiontext

Confab Laboratories Inc. is a privately held Canadian pharmaceutical Contract Development and Manufacturing Organization (CDMO) headquartered in a 100,200-square-foot facility in Saint-Hubert, Quebec. Founded in 1983 with roots tracing back more than four decades, the company specializes in non-sterile dosage forms — liquid, solid, and semi-solid — for prescription, over-the-counter, generic, controlled-substance, and veterinary pharmaceutical products. The integrated platform comprises 32 manufacturing suites and 17 packaging suites, an internal analytical laboratory with stability chambers, a 40,290-square-foot primary warehouse, an on-site mechanical workshop, and a Level 10 narcotic vault, all operating under FDA, Health Canada, EMEA mutual recognition, CFIA, Cofepris (Mexico), and PMDA (Japan) approvals.

Beyond manufacturing, Confab offers adjacent services including drug development (formulation and reverse engineering), technology transfer (engineering, regulatory, and validation batches), and pharmaceutical analysis (method development, verification, validation, transfer, and stability testing). Packaging capabilities include serialization and aggregation systems exceeding current mandatory traceability requirements, with vision systems for label compliance. The company serves enterprise pharmaceutical clients through a direct B2B sales motion — quote-based pricing driven by product type, packaging needs, target markets, and volume — with a dedicated project manager model providing continuity from development through commercialization. Global distribution of client products spans Canada, the United States, EMEA, Mexico, and Japan, supported from the single Quebec manufacturing site without disclosed offshore physical operations.

The business model is contract-based manufacturing revenue with multi-year client engagements and quote-driven, project-specific pricing rather than disclosed list pricing or subscription arrangements. Confab markets through its corporate website quote request system and standard professional social channels (LinkedIn, Facebook, YouTube, Instagram), targeting pharmaceutical companies seeking a single-source CDMO partner to reduce vendor management complexity across multiple dosage forms and regulatory jurisdictions. The company is independently owned with no disclosed private equity, venture capital, or parent-company control.

Short descriptiontext

Confab Laboratories Inc. is a privately held Canadian pharmaceutical CDMO that develops, manufactures, and packages non-sterile liquid, solid, and semi-solid dosage forms for prescription, OTC, generic, controlled, and veterinary pharmaceutical clients worldwide from its Saint-Hubert, Quebec facility.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersSaint-hubert, Canada
HQ citystring
Saint-hubert
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical contract manufacturing, CDMO services, drug development services, technology transfer services, pharmaceutical packaging services
Industry3 codes
PRIMARYHLAGABAG
Drug Substance–Drug Product Integrated CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGABAJ
Packaging, Labeling & Serialization (Clinical/Commercial) CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAIABAH
Generic Finished Dosage Form (FDF) Manufacturing
NAICS code2 codes
  • Pharmaceutical Preparation Manufacturing325412
  • Packaging and Labeling Services561910
SIC code2 codes
  • Pharmaceutical Preparations2834
  • Services-Medical Laboratories8071
Product category
Pharmaceutical Contract Manufacturing
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Contract Pharmaceutical Manufacturing
TypeOne Time License
Description

Full-service CDMO providing end-to-end pharmaceutical manufacturing including development, technology transfer, analytical services, and packaging for prescription and OTC medications, generics, controlled drugs, and veterinary products across liquid, solid, and semi-solid dosage forms

confab.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain
Pricing details1 tier
1Custom project-based pricing
ModelOtherBilling cadenceMulti-year contract
Notes

Quote-based pricing tailored to specific project requirements including product type (tablets, capsules, liquids, suppositories, creams, ointments, gels, powders), packaging requirements, target markets, annual volume expectations, and API classification

confab.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

CONFAB is a pharmaceutical Contract Development and Manufacturing Organization (CDMO) that manufactures and packages non-sterile dosage form products (liquid, solid, and semi-solid) for prescription and OTC medications, generics, controlled drugs, and veterinary products. The offering spans drug development, technology transfer, integrated analytical laboratory services, and packaging with serialization and aggregation capabilities, delivered under a single project manager from a 100,200-square-foot FDA-, Health Canada-, EMEA-, CFIA-, Cofepris-, and PMDA-approved facility in Saint-Hubert, Quebec.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Manufacturing approximately 15 different drugs for single clients with full-service capability from development through packaging
+1 more record
Product overview1 text field

CONFAB is a Contract Development and Manufacturing Organization (CDMO) offering comprehensive pharmaceutical manufacturing services. The company operates as a single unified offering encompassing manufacturing of non-sterile dosage forms (liquid, solid, and semi-solid) paired with integrated services including drug development, technology transfer, and pharmaceutical analysis. The product portfolio centers on manufacturing capabilities with complementary services that work together to provide end-to-end support from formulation through commercialization.

Product and service7 records
1Liquid Dose Pharmaceutical Manufacturing
CategoryLiquid Dose Manufacturing
Description

Contract manufacturing of pharmaceutical products in liquid form including solutions, suspensions, nasal sprays, oral products, topical products, syrups, and oils for pharmaceutical companies needing non-sterile liquid dosage manufacturing.

2Solid Dose Pharmaceutical Manufacturing
CategorySolid Dose Manufacturing
Description

Contract manufacturing of pharmaceutical products in solid form including tablets (core, coated, printed, printed and coated), capsules, single-dose powder pouches, powder in bulk, tablets-in-tablets, and capsules-in-capsules using low-shear, high-shear, wet, dry granulation, and direct compression methods for pharmaceutical companies.

3Semi-Solid Dose Pharmaceutical Manufacturing
CategorySemi-Solid Dose Manufacturing
Description

Contract manufacturing of pharmaceutical products in semi-solid form including rectal suppositories, vaginal ovules, creams, ointments, gels, and pastes for pharmaceutical companies requiring these dosage forms.

4Pharmaceutical Packaging Services
CategoryPharmaceutical Packaging
Description

Comprehensive packaging services for all dosage forms including bottles, droppers, syringes, jars, single-dose pouches, blister packs, with options for child-resistant caps, security seals, and serialization/aggregation capabilities for pharmaceutical companies.

5Drug Development Services
CategoryDrug Development Services
Description

Full-service pharmaceutical development including reverse engineering, complete drug development from concept, improvement of existing formulations, and development of manufacturing processes for liquid, solid, and semi-solid forms, designed for pharmaceutical companies seeking formulation through regulatory submission and commercial launch preparation support.

6Technology Transfer Services
CategoryTechnology Transfer Services
Description

Pharmaceutical technology transfer services adapting approved processes to CONFAB's facility, including engineering batches, pilot batches, clinical trial placebos, commercial scale-up batches, DOE studies, and process validation for pharmaceutical companies transferring manufacturing into CONFAB's facility.

7Pharmaceutical Analysis Services
CategoryAnalytical Laboratory Services
Description

Internal analytical laboratory services including raw material testing, packaging component testing, finished product testing, method development, verification, validation, method transfer, and stability chamber testing for pharmaceutical companies requiring turnkey analytical support.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Quebec-based pharmaceutical CDMO offering non-sterile solid, semi-solid, and liquid dose development and manufacturing with integrated analytical services - directly comparable to Confab in geography, dosage forms, and customer segment.

TypeDirect peer
Description

North American CDMO specializing in non-sterile solid, liquid, and semi-solid dosage forms for pharmaceutical companies, including a portfolio of pediatric and controlled products - closely comparable to Confab in scope and customer base.

TypeDirect peer
Description

Canadian pharmaceutical CDMO providing non-sterile manufacturing of solid, liquid, and semi-solid dosage forms with analytical and packaging services - directly comparable to Confab in geography, service mix, and small-to-mid-sized pharma customer focus.

4Recipharm
TypeBroad incumbent
Description

Large European pharmaceutical CDMO offering solid, semi-solid, and sterile manufacturing plus development services globally - comparable to Confab in non-sterile dose capabilities but operating at significantly broader scale across multiple continents.

TypeBroad incumbent
Description

European-headquartered CDMO offering solid, semi-solid, and liquid dose contract manufacturing plus packaging for pharmaceutical companies - comparable to Confab in dosage-form and packaging focus, though operating at much larger European-centric scale.

TypeBroad incumbent
Description

French pharmaceutical CDMO with pan-European manufacturing network for solid, liquid, semi-solid, and sterile dosage forms serving generics and branded pharma - comparable to Confab in non-sterile services and customer mix, but with broader geographic and sterile reach.

TypeBroad incumbent
Description

Global pharmaceutical CDMO offering oral, sterile, biologic, and inhaled dose manufacturing plus development services - overlaps Confab in solid/liquid/semi-solid but operates at vastly larger scale with sterile capabilities Confab lacks.

TypeBroad incumbent
Description

Global pharmaceutical services platform combining Patheon CDMO capabilities in API, oral solid, sterile, and biologics manufacturing - overlaps Confab in non-sterile dose services but offers the full integrated stack Confab cannot match.

TypeBroad incumbent
Description

Swiss global CDMO leader in biologics, cell and gene therapies, and small-molecule manufacturing with integrated development services - competes for non-sterile dose work but at massive scale and with capabilities beyond Confab's scope.

10Heraeus Pharma / Hälsa Pharma
TypeDirect peer
Description

Mid-sized pharmaceutical CDMO focused on solid oral dose manufacturing and packaging for pharma companies, comparable to Confab in dosage-form specialty and mid-market positioning but without Confab's controlled-substance and Canada-based capabilities.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance6 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

CONFAB

Pharmaceutical Contract Manufacturingconfab.com

Confab Laboratories Inc. is a privately held Canadian pharmaceutical CDMO that develops, manufactures, and packages non-sterile liquid, solid, and semi-solid dosage forms for prescription, OTC, generic, controlled, and veterinary pharmaceutical clients worldwide from its Saint-Hubert, Quebec facility.

What CONFAB does

Confab Laboratories Inc. is a privately held Canadian pharmaceutical Contract Development and Manufacturing Organization (CDMO) headquartered in a 100,200-square-foot facility in Saint-Hubert, Quebec. Founded in 1983 with roots tracing back more than four decades, the company specializes in non-sterile dosage forms — liquid, solid, and semi-solid — for prescription, over-the-counter, generic, controlled-substance, and veterinary pharmaceutical products. The integrated platform comprises 32 manufacturing suites and 17 packaging suites, an internal analytical laboratory with stability chambers, a 40,290-square-foot primary warehouse, an on-site mechanical workshop, and a Level 10 narcotic vault, all operating under FDA, Health Canada, EMEA mutual recognition, CFIA, Cofepris (Mexico), and PMDA (Japan) approvals.

Beyond manufacturing, Confab offers adjacent services including drug development (formulation and reverse engineering), technology transfer (engineering, regulatory, and validation batches), and pharmaceutical analysis (method development, verification, validation, transfer, and stability testing). Packaging capabilities include serialization and aggregation systems exceeding current mandatory traceability requirements, with vision systems for label compliance. The company serves enterprise pharmaceutical clients through a direct B2B sales motion — quote-based pricing driven by product type, packaging needs, target markets, and volume — with a dedicated project manager model providing continuity from development through commercialization. Global distribution of client products spans Canada, the United States, EMEA, Mexico, and Japan, supported from the single Quebec manufacturing site without disclosed offshore physical operations.

The business model is contract-based manufacturing revenue with multi-year client engagements and quote-driven, project-specific pricing rather than disclosed list pricing or subscription arrangements. Confab markets through its corporate website quote request system and standard professional social channels (LinkedIn, Facebook, YouTube, Instagram), targeting pharmaceutical companies seeking a single-source CDMO partner to reduce vendor management complexity across multiple dosage forms and regulatory jurisdictions. The company is independently owned with no disclosed private equity, venture capital, or parent-company control.

CONFAB firmographics

Firmographics
Name
CONFAB
Legal name
Confab Laboratories Inc.
Website
https://confab.com
Company type
Private
Founded year
1983
Operating status
Operating
Headcount range
101–250 employees
Short description
Confab Laboratories Inc. is a privately held Canadian pharmaceutical CDMO that develops, manufactures, and packages non-sterile liquid, solid, and semi-solid dosage forms for prescription, OTC, generic, controlled, and veterinary pharmaceutical clients worldwide from its Saint-Hubert, Quebec facility.
Ownership category
akta.pro rank

CONFAB industry classification

Industry
Product category
Pharmaceutical Contract Manufacturing
NAICS
Pharmaceutical Preparation Manufacturing (325412), Packaging and Labeling Services (561910)
SIC
Pharmaceutical Preparations (2834), Services-Medical Laboratories (8071)
akta.pro industry
PRIMARYHLAGABAG
Drug Substance–Drug Product Integrated CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGABAJ
Packaging, Labeling & Serialization (Clinical/Commercial) CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAIABAH
Generic Finished Dosage Form (FDF) Manufacturing

Keywords

  • Pharmaceutical contract manufacturing
  • CDMO services
  • Drug development services
  • Technology transfer services
  • Pharmaceutical packaging services

Where CONFAB is headquartered

Location

Headquarters

HQ city
Saint-hubert
HQ country
Canada
HQ region
North America

Offices1 record

Markets served

CONFAB business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

  1. Contract Pharmaceutical Manufacturing: Full-service CDMO providing end-to-end pharmaceutical manufacturing including development, technology transfer, analytical services, and packaging for prescription and OTC medications, generics, controlled drugs, and veterinary products across liquid, solid, and semi-solid dosage forms

Pricing tiers

ModelBillingPrice
OtherMulti-year contractCustom project-based pricing

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

CONFAB product offering

Product offering

Core offering

CONFAB is a pharmaceutical Contract Development and Manufacturing Organization (CDMO) that manufactures and packages non-sterile dosage form products (liquid, solid, and semi-solid) for prescription and OTC medications, generics, controlled drugs, and veterinary products. The offering spans drug development, technology transfer, integrated analytical laboratory services, and packaging with serialization and aggregation capabilities, delivered under a single project manager from a 100,200-square-foot FDA-, Health Canada-, EMEA-, CFIA-, Cofepris-, and PMDA-approved facility in Saint-Hubert, Quebec.

Product overview

CONFAB is a Contract Development and Manufacturing Organization (CDMO) offering comprehensive pharmaceutical manufacturing services. The company operates as a single unified offering encompassing manufacturing of non-sterile dosage forms (liquid, solid, and semi-solid) paired with integrated services including drug development, technology transfer, and pharmaceutical analysis. The product portfolio centers on manufacturing capabilities with complementary services that work together to provide end-to-end support from formulation through commercialization.

Differentiator

Problem solved

Functional benefit

Products and services

  • Liquid Dose Pharmaceutical Manufacturing Contract manufacturing of pharmaceutical products in liquid form including solutions, suspensions, nasal sprays, oral products, topical products, syrups, and oils for pharmaceutical companies needing non-sterile liquid dosage manufacturing.
  • Solid Dose Pharmaceutical Manufacturing Contract manufacturing of pharmaceutical products in solid form including tablets (core, coated, printed, printed and coated), capsules, single-dose powder pouches, powder in bulk, tablets-in-tablets, and capsules-in-capsules using low-shear, high-shear, wet, dry granulation, and direct compression methods for pharmaceutical companies.
  • Semi-Solid Dose Pharmaceutical Manufacturing Contract manufacturing of pharmaceutical products in semi-solid form including rectal suppositories, vaginal ovules, creams, ointments, gels, and pastes for pharmaceutical companies requiring these dosage forms.
  • Pharmaceutical Packaging Services Comprehensive packaging services for all dosage forms including bottles, droppers, syringes, jars, single-dose pouches, blister packs, with options for child-resistant caps, security seals, and serialization/aggregation capabilities for pharmaceutical companies.
  • Drug Development Services Full-service pharmaceutical development including reverse engineering, complete drug development from concept, improvement of existing formulations, and development of manufacturing processes for liquid, solid, and semi-solid forms, designed for pharmaceutical companies seeking formulation through regulatory submission and commercial launch preparation support.
  • Technology Transfer Services Pharmaceutical technology transfer services adapting approved processes to CONFAB's facility, including engineering batches, pilot batches, clinical trial placebos, commercial scale-up batches, DOE studies, and process validation for pharmaceutical companies transferring manufacturing into CONFAB's facility.
  • Pharmaceutical Analysis Services Internal analytical laboratory services including raw material testing, packaging component testing, finished product testing, method development, verification, validation, method transfer, and stability chamber testing for pharmaceutical companies requiring turnkey analytical support.

Quantifiable outcome

  • Manufacturing approximately 15 different drugs for single clients with full-service capability from development through packaging
  • +1 more outcomes

Companies that use CONFAB

Customer profile

Named customers4 records

Segments3 records

Ideal customer profiles3 records

CONFAB technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

CONFAB partnerships and signals

Strategic signal

Scale indicators8 records

Recent moves5 records

Expansion highlights5 records

CONFAB competitors and assessment

Company assessment

Direct peers

  • Corealis Pharma: Quebec-based pharmaceutical CDMO offering non-sterile solid, semi-solid, and liquid dose development and manufacturing with integrated analytical services - directly comparable to Confab in geography, dosage forms, and customer segment.
  • Halo Pharma: North American CDMO specializing in non-sterile solid, liquid, and semi-solid dosage forms for pharmaceutical companies, including a portfolio of pediatric and controlled products - closely comparable to Confab in scope and customer base.
  • Pillar5 Pharma (now part of Astrea BioSeparates): Canadian pharmaceutical CDMO providing non-sterile manufacturing of solid, liquid, and semi-solid dosage forms with analytical and packaging services - directly comparable to Confab in geography, service mix, and small-to-mid-sized pharma customer focus.
  • Heraeus Pharma / Hälsa Pharma: Mid-sized pharmaceutical CDMO focused on solid oral dose manufacturing and packaging for pharma companies, comparable to Confab in dosage-form specialty and mid-market positioning but without Confab's controlled-substance and Canada-based capabilities.

Broad incumbents

  • Recipharm: Large European pharmaceutical CDMO offering solid, semi-solid, and sterile manufacturing plus development services globally - comparable to Confab in non-sterile dose capabilities but operating at significantly broader scale across multiple continents.
  • Aenova Group: European-headquartered CDMO offering solid, semi-solid, and liquid dose contract manufacturing plus packaging for pharmaceutical companies - comparable to Confab in dosage-form and packaging focus, though operating at much larger European-centric scale.
  • Delpharm: French pharmaceutical CDMO with pan-European manufacturing network for solid, liquid, semi-solid, and sterile dosage forms serving generics and branded pharma - comparable to Confab in non-sterile services and customer mix, but with broader geographic and sterile reach.
  • Catalent: Global pharmaceutical CDMO offering oral, sterile, biologic, and inhaled dose manufacturing plus development services - overlaps Confab in solid/liquid/semi-solid but operates at vastly larger scale with sterile capabilities Confab lacks.
  • Thermo Fisher Scientific (Pharma Services / Patheon): Global pharmaceutical services platform combining Patheon CDMO capabilities in API, oral solid, sterile, and biologics manufacturing - overlaps Confab in non-sterile dose services but offers the full integrated stack Confab cannot match.
  • Lonza Group: Swiss global CDMO leader in biologics, cell and gene therapies, and small-molecule manufacturing with integrated development services - competes for non-sterile dose work but at massive scale and with capabilities beyond Confab's scope.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

CONFAB social profiles

Digital presence

CONFAB compliance and trust

Trust signal

Compliance6 records

CONFAB financial estimates

Financial estimate

Revenue estimate

Valuation estimate

CONFAB leadership team

Management profile

Number of profiles

CONFAB funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

CONFAB M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CONFAB

What does CONFAB do?

CONFAB is a pharmaceutical Contract Development and Manufacturing Organization (CDMO) that manufactures and packages non-sterile dosage form products (liquid, solid, and semi-solid) for prescription and OTC medications, generics, controlled drugs, and veterinary products. The offering spans drug development, technology transfer, integrated analytical laboratory services, and packaging with serialization and aggregation capabilities, delivered under a single project manager from a 100,200-square-foot FDA-, Health Canada-, EMEA-, CFIA-, Cofepris-, and PMDA-approved facility in Saint-Hubert, Quebec.

Is CONFAB a public or private company?

CONFAB is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was CONFAB founded?

CONFAB was founded in 1983. It employs 101 to 250 people.

Where is CONFAB based?

CONFAB is headquartered in Saint-hubert, Canada, in the North America region.

How does CONFAB make money?

One revenue line is on record: contract Pharmaceutical Manufacturing.

Who are CONFAB's main competitors?

Direct peers on record are Corealis Pharma, Halo Pharma, Pillar5 Pharma (now part of Astrea BioSeparates) and Heraeus Pharma / Hälsa Pharma. Broad incumbents are Recipharm, Aenova Group, Delpharm, Catalent, Thermo Fisher Scientific (Pharma Services / Patheon) and Lonza Group.

Does CONFAB have an API?

No public API is recorded for CONFAB.

What industry is CONFAB in?

CONFAB's product category is Pharmaceutical Contract Manufacturing. Its primary akta.pro industry code is HLAGABAG, Drug Substance–Drug Product Integrated CDMO, with a secondary code of HLAGABAJ, Packaging, Labeling & Serialization (Clinical/Commercial) CDMO. Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals